C3 complement inhibition prevents antibody-mediated rejection and prolongs renal allograft survival in sensitized non-human primates
出版年份 2021 全文链接
标题
C3 complement inhibition prevents antibody-mediated rejection and prolongs renal allograft survival in sensitized non-human primates
作者
关键词
-
出版物
Nature Communications
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-09-15
DOI
10.1038/s41467-021-25745-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
- (2020) Sara Mastaglio et al. CLINICAL IMMUNOLOGY
- Preoperative Carfilzomib and Lulizumab based desensitization prolongs graft survival in a sensitized non-human primate model.
- (2020) Paul M. Schroder et al. KIDNEY INTERNATIONAL
- OPTN/SRTR 2017 Annual Data Report: Kidney
- (2019) A. Hart et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients
- (2019) Brian Ezekian et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- B cells in transplant tolerance and rejection: friends or foes?
- (2019) Robin Schmitz et al. TRANSPLANT INTERNATIONAL
- The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
- (2018) M. Haas et al. AMERICAN JOURNAL OF TRANSPLANTATION
- New Analogs of the Complement C3 Inhibitor Compstatin with Increased Solubility and Improved Pharmacokinetic Profile
- (2018) Nadja Berger et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel Immunoassay for Complement Activation by PF4/Heparin Complexes
- (2018) Sanjay Khandelwal et al. THROMBOSIS AND HAEMOSTASIS
- Dual targeting: Combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients
- (2018) Christopher K. Burghuber et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Long‐term outcomes of eculizumab‐treated positive crossmatch recipients: Allograft survival, histologic findings, and natural history of the donor‐specific antibodies
- (2018) Carrie A. Schinstock et al. AMERICAN JOURNAL OF TRANSPLANTATION
- IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation
- (2017) Stanley C. Jordan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study
- (2016) R. A. Montgomery et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Antibody-Mediated Rejection in Sensitized Nonhuman Primates: Modeling Human Biology
- (2016) C. K. Burghuber et al. AMERICAN JOURNAL OF TRANSPLANTATION
- C1 Inhibitor in Acute Antibody-Mediated Rejection Nonresponsive to Conventional Therapy in Kidney Transplant Recipients: A Pilot Study
- (2016) D. Viglietti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Using an in vitro xenoantibody-mediated complement-dependent cytotoxicity model to evaluate the complement inhibitory activity of the peptidic C3 inhibitor Cp40
- (2016) Junxiang Wang et al. CLINICAL IMMUNOLOGY
- Multiplexed color-coded probe-based gene expression assessment for clinical molecular diagnostics in formalin-fixed paraffin-embedded human renal allograft tissue
- (2016) Benjamin Adam et al. CLINICAL TRANSPLANTATION
- Therapeutic control of complement activation at the level of the central component C3
- (2016) Daniel Ricklin et al. IMMUNOBIOLOGY
- Complement C3 inhibitor Cp40 attenuates xenoreactions in pig hearts perfused with human blood
- (2016) Jan-Michael Abicht et al. XENOTRANSPLANTATION
- Eculizumab Salvage Therapy for Antibody-Mediated Rejection in a Desensitization-Resistant Intestinal Re-Transplant Patient
- (2015) J. Fan et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention
- (2015) Dimitrios C. Mastellos et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- The Complement System and Antibody-Mediated Transplant Rejection
- (2015) Erik Stites et al. JOURNAL OF IMMUNOLOGY
- A Phase I/II Placebo-Controlled Trial of C1-Inhibitor for Prevention of Antibody-Mediated Rejection in HLA Sensitized Patients
- (2015) Ashley A. Vo et al. TRANSPLANTATION
- Do elderly recipients really benefit from kidney transplantation?
- (2015) Rachel Hellemans et al. Transplantation Reviews
- Antibody-mediated rejection despite inhibition of terminal complement
- (2014) Andrew Bentall et al. TRANSPLANT INTERNATIONAL
- Impact of IgM and IgG3 Anti-HLA Alloantibodies in Primary Renal Allograft Recipients
- (2014) Matthew J. Everly et al. TRANSPLANTATION
- Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
- (2013) Alexandre Loupy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eculizumab for Salvage Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: Case Reports
- (2013) B. Kocak et al. TRANSPLANTATION PROCEEDINGS
- Five-Year Outcomes in Living Donor Kidney Transplants With a Positive Crossmatch
- (2012) A. Bentall et al. AMERICAN JOURNAL OF TRANSPLANTATION
- New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties
- (2012) Hongchang Qu et al. IMMUNOBIOLOGY
- Treatment of hyperacute antibody-mediated lung allograft rejection with eculizumab
- (2012) Kyle L. Dawson et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Absence of signaling into CD4+ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3+ regulatory T cells
- (2012) Michael G Strainic et al. NATURE IMMUNOLOGY
- The role of complement in antibody-mediated rejection in kidney transplantation
- (2012) Mark D. Stegall et al. Nature Reviews Nephrology
- Complement Inhibition Enables Renal Allograft Accommodation and Long-Term Engraftment in Presensitized Nonhuman Primates
- (2011) S. Chen Song et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients
- (2011) M. D. Stegall et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes
- (2011) M. Tonelli et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Desensitization in HLA-Incompatible Kidney Recipients and Survival
- (2011) Robert A. Montgomery et al. NEW ENGLAND JOURNAL OF MEDICINE
- Complement fragments C3a and C5a: The salt and pepper of the immune response
- (2010) Steven H. Sacks EUROPEAN JOURNAL OF IMMUNOLOGY
- Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
- (2010) C. Lefaucheur et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Accommodation in organ transplantation
- (2009) Raymond J Lynch et al. Current Opinion in Organ Transplantation
- C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells
- (2009) Donald J. Weaver et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Alloantibody Levels and Acute Humoral Rejection Early After Positive Crossmatch Kidney Transplantation
- (2008) J. M. Burns et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis
- (2008) P. N. Lalli et al. BLOOD
- Locally Produced Complement Fragments C5a and C3a Provide Both Costimulatory and Survival Signals to Naive CD4+ T Cells
- (2008) Michael G. Strainic et al. IMMUNITY
- Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation
- (2008) Ashley A. Vo et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started